What Medtronic's Earnings Mean for Mutual Fund Investors (MDT)

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Fixed income news, reports, video and more.

Municipal bonds news, reports, video and more.

Practice management news, reports, video and more.

Portfolio management news, reports, video and more.

Retirement news, reports, video and more.

Learn from industry thought leaders and expert market participants.

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

What Medtronic's Earnings Mean for Mutual Fund Investors (MDT)

Medtronic logo in blue
Before Tuesday’s opening bell, Medtronic (MDT) released its third quarter financial results. Here’s what the results mean for mutual fund investors.

Inside MDT’s Results

Earnings

MDT reported earnings of $977 million, or 98 cents per share, up from $762 million, or 75 cents per share, a year ago. Adjusted EPS was $1.01 – above analysts’ estimate of 97 cents.

Revenue
Revenue increased to $4.318 billion from $4.163 billion last year. Analysts expected to see revenue of $4.25 billion.

Covidien Deal Will Keep Medtronic Diversified

At the end of January, Medtronic closed its $43 billion merger deal with Ireland-based Covidien. The deal will allow the company to re-incorporate in Ireland and will also provide the company with much needed diversification. This new diversification will partially offset the loss of market share in some of its businesses.

Mutual Funds to Watch

Investors interested in MDT may be interested in the funds listed below. These funds currently have the largest stakes in the company.

The Bottom Line

The funds listed above allow investors to gain exposure to MDT while remaining diversified. Investors interested in MDT may also be interested in St. Jude Medical (STJ) and Boston Scientific (BSX).

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Popular Articles

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.


Read Next

Medtronic logo in blue

What Medtronic's Earnings Mean for Mutual Fund Investors (MDT)

Before Tuesday’s opening bell, Medtronic (MDT) released its third quarter financial results. Here’s what the results mean for mutual fund investors.

Inside MDT’s Results

Earnings

MDT reported earnings of $977 million, or 98 cents per share, up from $762 million, or 75 cents per share, a year ago. Adjusted EPS was $1.01 – above analysts’ estimate of 97 cents.

Revenue
Revenue increased to $4.318 billion from $4.163 billion last year. Analysts expected to see revenue of $4.25 billion.

Covidien Deal Will Keep Medtronic Diversified

At the end of January, Medtronic closed its $43 billion merger deal with Ireland-based Covidien. The deal will allow the company to re-incorporate in Ireland and will also provide the company with much needed diversification. This new diversification will partially offset the loss of market share in some of its businesses.

Mutual Funds to Watch

Investors interested in MDT may be interested in the funds listed below. These funds currently have the largest stakes in the company.

The Bottom Line

The funds listed above allow investors to gain exposure to MDT while remaining diversified. Investors interested in MDT may also be interested in St. Jude Medical (STJ) and Boston Scientific (BSX).

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Popular Articles

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.


Read Next